Clinical trials
Thalassemia trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HaEmek Medical Center, Israel | 2 |
| The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine | 2 |
| Weill Medical College of Cornell University | 2 |
| Xiao-Lin Yin | 2 |
| 404 General Military Hospital, Larissa | 1 |
| Allife Medical Science and Technology Co., Ltd. | 1 |
| Assiut University | 1 |
| Chiang Mai University | 1 |
| Columbia University | 1 |
| Fakultas Kedokteran Universitas Indonesia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thalassemia | 23 |
| beta-Thalassemia | 5 |
| Anemia, Sickle Cell | 2 |
| Anemia | 1 |
| Coronary Artery Disease | 1 |
| Hemoglobin C Disease | 1 |
| Hemoglobin SC Disease | 1 |
| Hemosiderosis | 1 |
| Hypercalciuria | 1 |
| Iron Deficiencies | 1 |
Trials
Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.